Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alkindi 0.5mg granules in capsules for opening
0603020J0BFAACX
|
Alkindi | Hydrocortisone | Endocrine System | 291 |
|
Plenadren 20mg modified-release tablets
0603020J0BEABCW
|
Plenadren | Hydrocortisone | Endocrine System | 291 |
|
Anusol Soothing Relief ointment
0107020J0BCAFAC
|
Anusol HC | Hydrocortisone | Gastro-Intestinal System | 280 |
|
Hydrocortisone 10mg dispersible tablets sugar free
0603020J0AADIDI
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 275 |
|
Hydrocortisone 2mg granules in capsules for opening
0603020J0AACZCZ
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 224 |
|
Hydrocortisone 1mg granules in capsules for opening
0603020J0AACYCY
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 210 |
|
Hydrocortisone 20mg modified-release tablets
0603020J0AACWCW
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 194 |
|
Hydrocortisone 500microgram granules in capsules for opening
0603020J0AACXCX
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 173 |
|
Alkindi 5mg granules in capsules for opening
0603020J0BFADDA
|
Alkindi | Hydrocortisone | Endocrine System | 169 |
|
Plenadren 5mg modified-release tablets
0603020J0BEAACV
|
Plenadren | Hydrocortisone | Endocrine System | 156 |
|
Hydrocortisone 10mg/5ml oral suspension
0603020J0AAAKAK
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 139 |
|
Anusol Soothing Relief suppositories
0107020J0BCAEAB
|
Anusol HC | Hydrocortisone | Gastro-Intestinal System | 135 |
|
Lidocaine 1% / Hydrocortisone 0.2% spray
0107020J0AAAJAJ
|
Hydrocortisone compound preparations | Hydrocortisone | Gastro-Intestinal System | 101 |
|
Efmody 5mg modified-release capsules
0603020J0BHAADF
|
Efmody | Hydrocortisone | Endocrine System | 96 |
|
Perinal spray
0107020J0BHAAAJ
|
Perinal | Hydrocortisone | Gastro-Intestinal System | 95 |
|
Hydrocortisone 5mg/5ml oral solution
0603020J0AAAJAJ
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 91 |
|
Hydrocortisone 5mg dispersible tablets sugar free
0603020J0AADHDH
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 81 |
|
Hydrocortisone 5mg granules in capsules for opening
0603020J0AADADA
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 72 |
|
Efmody 10mg modified-release capsules
0603020J0BHABDG
|
Efmody | Hydrocortisone | Endocrine System | 68 |
|
Hydventia 20mg tablets
0603020J0BGABAE
|
Hydventia | Hydrocortisone | Endocrine System | 46 |
|
Hydrocortisone 10mg/5ml oral solution sugar free
0603020J0AADLDL
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 43 |
|
Hydrocortisone 5mg modified-release capsules
0603020J0AADFDF
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 40 |
|
Hydrocortisone 10mg modified-release capsules
0603020J0AADGDG
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 37 |
|
Hydrocortone 10mg tablets
0603020J0BCAAAD
|
Hydrocortone | Hydrocortisone | Endocrine System | 22 |
|
Dermacort hydrocortisone 0.1% cream
1304000V0BNAAAW
|
Dermacort | Hydrocortisone | Skin | 17 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.